WHO ICTRP trial
Effect of glargine insulin on hyperglycemic control in type II diabetic patients
IRCT20130428013159N11 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20130428013159N11 |
|---|---|
| Public title | Effect of glargine insulin on hyperglycemic control in type II diabetic patients |
| Scientific title | A clinical trial to compare the effectiveness of glargine insulin and regular insulin in hyperglycemic control among type II diabetic patients undergoing off-pump coronary artery bypass graft surgery |
| Primary sponsor | Mashhad University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 2-3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | type II diabetic. Type 2 diabetes mellitus |
| Interventions | Intervention 1: The intervention group will receive 0.1 mg/kg units/kg glargine insulin 2 hours before the surgery. Based on the Van den Berghe national protocol, regular insulin injection unit is equivalent to the blood glucose of patient… |
| Registration date | Mar 14, 2020 |
| Target size | 80 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: